Functional analysis of disease-associated polymorphism LRP5.Q89R

Weiming Mao, Robert J. Wordinger, Abbot F. Clark

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: The canonical wingless and Int1 (Wnt) signaling pathway plays key roles in multiple biologic events. The pathway co-receptor, low density lipoprotein receptor-related protein 5 (LRP5), is involved in the pathogenesis of retinal diseases and has been implicated in glaucoma. We studied whether a disease-associated polymorphism LRP5.Q89R, which is located in the second blade of the first β-propeller domain, directly alters Wnt signaling activity with cell-based assays. Methods: The LRP5.Q89R polymorphism was evaluated by trans fection of HEK293T or GTM3 cells with expression vectors. LRP5 expression and interaction with the molecular chaperone mesoderm development (MESD) were determined by western immunoblotting and co-immuno precipitation analyses. To compare membrane-associated LRP5 proteins, surface proteins were labeled with biotin and pulled down with avidin beads followed by western immunoblotting. TCF reporter plasmid-based luci ferase assays were used to determine whether LRP5.Q89R affects the canonical Wnt signaling, or has altered efficacy to suppression by Dickkopf-1 (DKK-1). Results: Cell-based assays showed that this polymorphism did not change protein expression, interaction with the molecular chaperone MESD, protein trafficking, Wnt signaling transduction, or its efficacy in DKK1-mediated inhibition. Conclusions: Our data suggest that this specific polymorphism does not appear to alter the canonical Wnt signaling pathway. Further studies of LRP5 polymorphisms are needed to elucidate their roles in various associated diseases.

Original languageEnglish (US)
Pages (from-to)894-902
Number of pages9
JournalMolecular Vision
Volume17
StatePublished - May 9 2011
Externally publishedYes

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-5
Wnt Signaling Pathway
Molecular Chaperones
Mesoderm
Western Blotting
Retinal Diseases
Avidin
Protein Transport
Biotin
Glaucoma
Membrane Proteins
Proteins
Plasmids
Membranes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Mao, W., Wordinger, R. J., & Clark, A. F. (2011). Functional analysis of disease-associated polymorphism LRP5.Q89R. Molecular Vision, 17, 894-902.

Functional analysis of disease-associated polymorphism LRP5.Q89R. / Mao, Weiming; Wordinger, Robert J.; Clark, Abbot F.

In: Molecular Vision, Vol. 17, 09.05.2011, p. 894-902.

Research output: Contribution to journalArticle

Mao, W, Wordinger, RJ & Clark, AF 2011, 'Functional analysis of disease-associated polymorphism LRP5.Q89R', Molecular Vision, vol. 17, pp. 894-902.
Mao, Weiming ; Wordinger, Robert J. ; Clark, Abbot F. / Functional analysis of disease-associated polymorphism LRP5.Q89R. In: Molecular Vision. 2011 ; Vol. 17. pp. 894-902.
@article{bc0ceb3256f847adb900d90d0272a446,
title = "Functional analysis of disease-associated polymorphism LRP5.Q89R",
abstract = "Purpose: The canonical wingless and Int1 (Wnt) signaling pathway plays key roles in multiple biologic events. The pathway co-receptor, low density lipoprotein receptor-related protein 5 (LRP5), is involved in the pathogenesis of retinal diseases and has been implicated in glaucoma. We studied whether a disease-associated polymorphism LRP5.Q89R, which is located in the second blade of the first β-propeller domain, directly alters Wnt signaling activity with cell-based assays. Methods: The LRP5.Q89R polymorphism was evaluated by trans fection of HEK293T or GTM3 cells with expression vectors. LRP5 expression and interaction with the molecular chaperone mesoderm development (MESD) were determined by western immunoblotting and co-immuno precipitation analyses. To compare membrane-associated LRP5 proteins, surface proteins were labeled with biotin and pulled down with avidin beads followed by western immunoblotting. TCF reporter plasmid-based luci ferase assays were used to determine whether LRP5.Q89R affects the canonical Wnt signaling, or has altered efficacy to suppression by Dickkopf-1 (DKK-1). Results: Cell-based assays showed that this polymorphism did not change protein expression, interaction with the molecular chaperone MESD, protein trafficking, Wnt signaling transduction, or its efficacy in DKK1-mediated inhibition. Conclusions: Our data suggest that this specific polymorphism does not appear to alter the canonical Wnt signaling pathway. Further studies of LRP5 polymorphisms are needed to elucidate their roles in various associated diseases.",
author = "Weiming Mao and Wordinger, {Robert J.} and Clark, {Abbot F.}",
year = "2011",
month = "5",
day = "9",
language = "English (US)",
volume = "17",
pages = "894--902",
journal = "Molecular Vision",
issn = "1090-0535",

}

TY - JOUR

T1 - Functional analysis of disease-associated polymorphism LRP5.Q89R

AU - Mao, Weiming

AU - Wordinger, Robert J.

AU - Clark, Abbot F.

PY - 2011/5/9

Y1 - 2011/5/9

N2 - Purpose: The canonical wingless and Int1 (Wnt) signaling pathway plays key roles in multiple biologic events. The pathway co-receptor, low density lipoprotein receptor-related protein 5 (LRP5), is involved in the pathogenesis of retinal diseases and has been implicated in glaucoma. We studied whether a disease-associated polymorphism LRP5.Q89R, which is located in the second blade of the first β-propeller domain, directly alters Wnt signaling activity with cell-based assays. Methods: The LRP5.Q89R polymorphism was evaluated by trans fection of HEK293T or GTM3 cells with expression vectors. LRP5 expression and interaction with the molecular chaperone mesoderm development (MESD) were determined by western immunoblotting and co-immuno precipitation analyses. To compare membrane-associated LRP5 proteins, surface proteins were labeled with biotin and pulled down with avidin beads followed by western immunoblotting. TCF reporter plasmid-based luci ferase assays were used to determine whether LRP5.Q89R affects the canonical Wnt signaling, or has altered efficacy to suppression by Dickkopf-1 (DKK-1). Results: Cell-based assays showed that this polymorphism did not change protein expression, interaction with the molecular chaperone MESD, protein trafficking, Wnt signaling transduction, or its efficacy in DKK1-mediated inhibition. Conclusions: Our data suggest that this specific polymorphism does not appear to alter the canonical Wnt signaling pathway. Further studies of LRP5 polymorphisms are needed to elucidate their roles in various associated diseases.

AB - Purpose: The canonical wingless and Int1 (Wnt) signaling pathway plays key roles in multiple biologic events. The pathway co-receptor, low density lipoprotein receptor-related protein 5 (LRP5), is involved in the pathogenesis of retinal diseases and has been implicated in glaucoma. We studied whether a disease-associated polymorphism LRP5.Q89R, which is located in the second blade of the first β-propeller domain, directly alters Wnt signaling activity with cell-based assays. Methods: The LRP5.Q89R polymorphism was evaluated by trans fection of HEK293T or GTM3 cells with expression vectors. LRP5 expression and interaction with the molecular chaperone mesoderm development (MESD) were determined by western immunoblotting and co-immuno precipitation analyses. To compare membrane-associated LRP5 proteins, surface proteins were labeled with biotin and pulled down with avidin beads followed by western immunoblotting. TCF reporter plasmid-based luci ferase assays were used to determine whether LRP5.Q89R affects the canonical Wnt signaling, or has altered efficacy to suppression by Dickkopf-1 (DKK-1). Results: Cell-based assays showed that this polymorphism did not change protein expression, interaction with the molecular chaperone MESD, protein trafficking, Wnt signaling transduction, or its efficacy in DKK1-mediated inhibition. Conclusions: Our data suggest that this specific polymorphism does not appear to alter the canonical Wnt signaling pathway. Further studies of LRP5 polymorphisms are needed to elucidate their roles in various associated diseases.

UR - http://www.scopus.com/inward/record.url?scp=79955595755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955595755&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 894

EP - 902

JO - Molecular Vision

JF - Molecular Vision

SN - 1090-0535

ER -